Key Market Indicators
Sales of antacid medicine in Germany are set to hit $23.11 million by 2026. In 2021, the market was worth $26.07 million, a year-on-year decrease of 1.6%. Since 1991, German sales have grown by an average of 4.3% annually. In 2021, Italy overtook Germany's market, coming in at second place with $26.07 million, followed by Germany and Chile respectively.
